What does circulating tumor DNA (ctDNA) testing tell me about my Lymphoma
Understanding Circulating Tumor DNA (ctDNA) Testing for Lymphoma
Circulating tumor DNA (ctDNA) testing is an emerging blood-based test that detects tiny fragments of cancer DNA floating in your bloodstream. For lymphoma patients, this test can provide important information about how your cancer is responding to treatment and help predict whether your disease might return.
What ctDNA Testing Measures
When lymphoma cells die—either naturally or from treatment—they release DNA fragments into your blood. ctDNA testing detects these cancer-specific DNA fragments at very low levels. Think of it like finding a few grains of sand on a beach; the test is looking for that specific cancer "signature" in your blood.
For B-cell lymphomas (which includes many common types like diffuse large B-cell lymphoma and follicular lymphoma), ctDNA testing can identify the unique genetic patterns that make your cancer cells different from normal cells.
What This Means for Monitoring Your Lymphoma
According to the NCCN Guidelines for B-Cell Lymphomas (updated December 2024), ctDNA testing—specifically molecular residual disease (MRD) testing—is now included in treatment monitoring strategies. Here's what it can tell you:
After Treatment (End-of-Treatment Testing):
- Detects remaining cancer cells that might not show up on imaging scans yet
- Predicts relapse risk: Studies show ctDNA testing can identify patients at higher risk of their lymphoma returning before symptoms appear
- Earlier detection: ctDNA can detect recurrence approximately 200 days (about 6-7 months) earlier than PET/CT imaging in diffuse large B-cell lymphoma
During Surveillance:
- Helps guide how often you need imaging scans
- May influence decisions about additional treatment (called adjuvant therapy)
- Provides reassurance if results remain negative over time
How Accurate Is ctDNA Testing?
For lymphoma patients, ctDNA testing shows strong performance:
- Sensitivity: 90.62% (meaning it correctly identifies about 90% of patients who will later relapse)
- Specificity: 97.65% (meaning it correctly identifies about 98% of patients who won't relapse)
- Lead time advantage: Detects relapse approximately 200 days before PET/CT imaging
For comparison, traditional PET/CT imaging identified only 45% of patients who later relapsed, while ctDNA identified 90%.
Important Limitations and Considerations
Current Status:
- ctDNA testing for lymphoma is still relatively new in clinical practice
- The specific test (Foresight CLARITY Lymphoma) is currently available through research trials and limited clinical use, with broader clinical availability expected in 2026
- It requires a prior tumor tissue sample to establish your cancer's unique genetic signature (called "tumor-informed" testing)
What It Cannot Do:
- ctDNA testing is not a replacement for imaging scans or physical exams
- It doesn't diagnose lymphoma initially—it's used for monitoring after diagnosis
- A negative ctDNA result doesn't guarantee your lymphoma won't return; it means no detectable cancer DNA at that moment
Questions to Ask Your Oncology Team
If ctDNA testing interests you, consider asking your care team:
- "Is ctDNA/MRD testing appropriate for my specific type of lymphoma and stage of treatment?"
- "Would this test change how often I need imaging scans or affect my treatment plan?"
- "Is this test available through your clinic, or would I need to participate in a clinical trial?"
- "How would you use the results to guide my follow-up care?"
- "What would a positive ctDNA result mean for my treatment options?"
The Bottom Line
ctDNA testing represents an exciting advancement in lymphoma monitoring that can detect cancer recurrence much earlier than traditional imaging. However, it's still being integrated into standard care. Your oncologist will determine whether this test is appropriate for your specific situation and how it fits into your overall treatment and surveillance plan.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients (Lymphomas) — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated May 17, 2026. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients (Lymphomas) (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with general for Lymphoma patients
Have your records handy? Add them to a private case for a deeper, personalized read →
Expert Webinars on Lymphoma
More questions about Lymphoma
- What biomarker testing is recommended for metastatic Lymphoma
- What does tumor mutational burden (TMB) mean for Lymphoma
- What is a multidisciplinary tumor board and should my Lymphoma case be presented
- When you are in remission from your FL, which statistically is likely to return, do you still tell people you have...
- Hello! My diagnosis is classic follicular lymphoma high grade 3A. It was found through testing my tonsils after...
- I would like to hear from anyone who have or had tumor growth on their skin. * What kind of treatment are you...
- For anyone who has this in their bone marrow, can u tell me what, if any, ur symptoms were? And what original test...
- What does progression mean for Lymphoma and what happens next